Correlation Between Madrigal Pharmaceuticals and Biomarin Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Madrigal Pharmaceuticals and Biomarin Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Madrigal Pharmaceuticals and Biomarin Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Madrigal Pharmaceuticals and Biomarin Pharmaceutical, you can compare the effects of market volatilities on Madrigal Pharmaceuticals and Biomarin Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Madrigal Pharmaceuticals with a short position of Biomarin Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Madrigal Pharmaceuticals and Biomarin Pharmaceutical.
Diversification Opportunities for Madrigal Pharmaceuticals and Biomarin Pharmaceutical
-0.36 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Madrigal and Biomarin is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Madrigal Pharmaceuticals and Biomarin Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biomarin Pharmaceutical and Madrigal Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Madrigal Pharmaceuticals are associated (or correlated) with Biomarin Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biomarin Pharmaceutical has no effect on the direction of Madrigal Pharmaceuticals i.e., Madrigal Pharmaceuticals and Biomarin Pharmaceutical go up and down completely randomly.
Pair Corralation between Madrigal Pharmaceuticals and Biomarin Pharmaceutical
Given the investment horizon of 90 days Madrigal Pharmaceuticals is expected to generate 2.0 times more return on investment than Biomarin Pharmaceutical. However, Madrigal Pharmaceuticals is 2.0 times more volatile than Biomarin Pharmaceutical. It trades about 0.03 of its potential returns per unit of risk. Biomarin Pharmaceutical is currently generating about -0.05 per unit of risk. If you would invest 25,748 in Madrigal Pharmaceuticals on November 1, 2024 and sell it today you would earn a total of 7,669 from holding Madrigal Pharmaceuticals or generate 29.78% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 99.8% |
| Values | Daily Returns |
Madrigal Pharmaceuticals vs. Biomarin Pharmaceutical
Performance |
| Timeline |
| Madrigal Pharmaceuticals |
| Biomarin Pharmaceutical |
Madrigal Pharmaceuticals and Biomarin Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Madrigal Pharmaceuticals and Biomarin Pharmaceutical
The main advantage of trading using opposite Madrigal Pharmaceuticals and Biomarin Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Madrigal Pharmaceuticals position performs unexpectedly, Biomarin Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomarin Pharmaceutical will offset losses from the drop in Biomarin Pharmaceutical's long position.| Madrigal Pharmaceuticals vs. Surrozen | Madrigal Pharmaceuticals vs. Armata Pharmaceuticals | Madrigal Pharmaceuticals vs. Pasithea Therapeutics Corp | Madrigal Pharmaceuticals vs. Aditxt Inc |
| Biomarin Pharmaceutical vs. Alnylam Pharmaceuticals | Biomarin Pharmaceutical vs. Exelixis | Biomarin Pharmaceutical vs. Halozyme Therapeutics | Biomarin Pharmaceutical vs. Arrowhead Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |